190 related articles for article (PubMed ID: 32165607)
21. Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients.
Agopian VG; Morshedi MM; McWilliams J; Harlander-Locke MP; Markovic D; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Hiatt JR; Busuttil RW
Ann Surg; 2015 Sep; 262(3):536-45; discussion 543-5. PubMed ID: 26258323
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma: Can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?
Moya A; Berenguer M; Aguilera V; Juan FS; Nicolás D; Pastor M; López-Andujar R; Rayón M; Orbis F; Mora J; De Juan M; Carrasco D; Vila JJ; Prieto M; Berenguer J; Mir J
Liver Transpl; 2002 Nov; 8(11):1020-7. PubMed ID: 12424715
[TBL] [Abstract][Full Text] [Related]
23. Is there increased risk of hepatocellular carcinoma recurrence in liver transplant patients with direct-acting antiviral therapy?
Jain A; Miller D; Schreibman I; Riley TR; Krok KL; Dohi T; Sharma R; Kadry Z
Hepatol Int; 2019 Mar; 13(2):190-198. PubMed ID: 30680672
[TBL] [Abstract][Full Text] [Related]
24. Early-phase circulating miRNAs predict tumor recurrence and survival of hepatocellular carcinoma patients after liver transplantation.
Ng KT; Lo CM; Wong N; Li CX; Qi X; Liu XB; Geng W; Yeung OW; Ma YY; Chan SC; Man K
Oncotarget; 2016 Apr; 7(15):19824-39. PubMed ID: 26918346
[TBL] [Abstract][Full Text] [Related]
25. Improved results of transplantation for hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation.
Onaca N; Davis GL; Jennings LW; Goldstein RM; Klintmalm GB
Liver Transpl; 2009 Jun; 15(6):574-80. PubMed ID: 19479800
[TBL] [Abstract][Full Text] [Related]
26. Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome.
Herber S; Biesterfeld S; Franz U; Schneider J; Thies J; Schuchmann M; Düber C; Pitton MB; Otto G
Cardiovasc Intervent Radiol; 2008; 31(4):768-77. PubMed ID: 18196335
[TBL] [Abstract][Full Text] [Related]
27. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?
Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP
J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474
[TBL] [Abstract][Full Text] [Related]
28. Construction of TME and Identification of crosstalk between malignant cells and macrophages by SPP1 in hepatocellular carcinoma.
Liu L; Zhang R; Deng J; Dai X; Zhu X; Fu Q; Zhang H; Tong Z; Zhao P; Fang W; Zheng Y; Bao X
Cancer Immunol Immunother; 2022 Jan; 71(1):121-136. PubMed ID: 34028567
[TBL] [Abstract][Full Text] [Related]
29. Liver transplantation versus supraselective transarterial chemoembolization in palliative patients with hepatocellular carcinoma exceeding the Milan Criteria - is it time for a more individual approach?
Heinzow HS; Brockmann JG; Köhler M; Wolters HH; Senninger N; Schmidt H; Meister T
Ann Transplant; 2013 Oct; 18():515-24. PubMed ID: 24081430
[TBL] [Abstract][Full Text] [Related]
30. Liver transplantation for advanced hepatocellular carcinoma using poor tumor differentiation on biopsy as an exclusion criterion.
DuBay D; Sandroussi C; Sandhu L; Cleary S; Guba M; Cattral MS; McGilvray I; Ghanekar A; Selzner M; Greig PD; Grant DR
Ann Surg; 2011 Jan; 253(1):166-72. PubMed ID: 21294289
[TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of TIE2-expressing monocytes in hilar cholangiocarcinoma.
Atanasov G; Hau HM; Dietel C; Benzing C; Krenzien F; Brandl A; Englisch JP; Wiltberger G; Schierle K; Robson SC; Reutzel-Selke A; Jonas S; Pascher A; Pratschke J; Schmelzle M
J Surg Oncol; 2016 Jul; 114(1):91-8. PubMed ID: 27111031
[TBL] [Abstract][Full Text] [Related]
32. A novel prognostic nomogram accurately predicts hepatocellular carcinoma recurrence after liver transplantation: analysis of 865 consecutive liver transplant recipients.
Agopian VG; Harlander-Locke M; Zarrinpar A; Kaldas FM; Farmer DG; Yersiz H; Finn RS; Tong M; Hiatt JR; Busuttil RW
J Am Coll Surg; 2015 Apr; 220(4):416-27. PubMed ID: 25690672
[TBL] [Abstract][Full Text] [Related]
33. Immune Checkpoint Inhibitors in Patients with Recurrent Hepatocellular Carcinoma after Liver Transplantation: A Case Report and Literature Review.
Qiu J; Tang W; Du C
Curr Cancer Drug Targets; 2020; 20(9):720-727. PubMed ID: 32433005
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of polarized macrophages in patients with hepatocellular carcinoma after curative resection.
Shu QH; Ge YS; Ma HX; Gao XQ; Pan JJ; Liu D; Xu GL; Ma JL; Jia WD
J Cell Mol Med; 2016 Jun; 20(6):1024-35. PubMed ID: 26843477
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of Simultaneous Liver Kidney Transplantation in Patients With Hepatocellular Carcinoma.
Rich N; Tanriover B; Singal AG; Marrero JA
Transplantation; 2017 Jan; 101(1):e12-e19. PubMed ID: 28009759
[TBL] [Abstract][Full Text] [Related]
36. Liver transplantation for hepatocellular carcinoma: long-term results suggest excellent outcomes.
Doyle MB; Vachharajani N; Maynard E; Shenoy S; Anderson C; Wellen JR; Lowell JA; Chapman WC
J Am Coll Surg; 2012 Jul; 215(1):19-28; discussion 28-30. PubMed ID: 22608403
[TBL] [Abstract][Full Text] [Related]
37. Liver transplantation for hepatocellular carcinoma: an update.
Zarrinpar A; Kaldas F; Busuttil RW
Hepatobiliary Pancreat Dis Int; 2011 Jun; 10(3):234-42. PubMed ID: 21669564
[TBL] [Abstract][Full Text] [Related]
38. CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis.
Dong P; Ma L; Liu L; Zhao G; Zhang S; Dong L; Xue R; Chen S
Int J Mol Sci; 2016 Mar; 17(3):320. PubMed ID: 26938527
[TBL] [Abstract][Full Text] [Related]
39. The impact of transarterial chemoembolization induced complications on outcomes after liver transplantation: A propensity-matched study.
Boteon APCDS; Boteon YL; Vinuela EF; Derosas C; Mergental H; Isaac JR; Muiesan P; Mehzard H; Ma YT; Shah T; Mirza DF; Perera MTPR
Clin Transplant; 2018 May; 32(5):e13255. PubMed ID: 29637619
[TBL] [Abstract][Full Text] [Related]
40. Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention-to-treat analysis.
de Haas RJ; Lim C; Bhangui P; Salloum C; Compagnon P; Feray C; Calderaro J; Luciani A; Azoulay D
Hepatology; 2018 Jan; 67(1):204-215. PubMed ID: 28806477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
